Business Standard

'Great day for humanity': Pfizer says Covid-19 vaccine over 90% effective

President-elect Joe Biden said the news was excellent but did not change the fact that face masks, social distancing would be needed well into next year

Photo courtesy: Reuters
Premium

The U.S. drugmaker said the interim analysis was conducted after 94 participants in the trial developed Covid-19, examining how many of them had received the vaccine versus a placebo. |Photo courtesy: Reuters

Michael Erman and Julie Steenhuysen | Reuters
Pfizer Inc's experimental Covid-19 vaccine was more than 90% effective based on initial trial results, the company said on Monday, a major victory in the fight against a pandemic that has killed over a million people and battered the world's economy.
Experts welcomed the first successful interim data from a large-scale clinical test as a watershed moment that showed vaccines could halt the pandemic though mass roll-outs of the shot, which needs regulatory approval, won't happen this year.
Pfizer and its German partner BioNTech SE said they had so far found no serious safety concerns and expected to seek U.S. authorization this

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in